Clearpoint Neuro Inc reports results for the quarter ended in March - Earnings Summary

Clearpoint Neuro

12/05/2021 24:14

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly adjusted
loss of 13 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 14 cents per share.
* Revenue rose 29.4% to $4.03 million from a year ago;  analysts
expected $3.27 million. 
* Clearpoint Neuro Inc's reported EPS for the quarter was a loss
of 13 cents​.
* The mean earnings estimate of analysts had risen by about 3.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Clearpoint Neuro Inc shares had fallen by 18.2% this
quarter and gained 8.9% so far this year.
* The company reported a quarterly loss of $2.54 million.
* Wall Street's median 12-month price target for Clearpoint
Neuro Inc is $35.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 11:14 p.m. GMT.
​All figures in US dollars